SecBot SecBot
SC 13G ·Filed Nov 10, 2026

CTMX

CytomX Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6d 20h ago SEC0000093751-26-000642
Passive investor 5%+ stake
Actionable Insight • Neutral

State Street's stake is below the 5% threshold, so no further 13G amendments are required unless it crosses back above 5%. Monitor for any future 13D conversion or material changes in institutional ownership.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$1.98
T+0 close · Nov 10, 2026 · via day close
Latest settled
+7.58%
T+1 · $2.13
Vs SPY
+6.26%
α at T+1
Next horizon
T+5
in 3h
  1. T+0 · Nov 10 $1.98entry
  2. T+1 · 6d ago +7.58%α +6.26% · $2.13
  3. T+4 · todayOpen
  4. T+5 · in 3h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

State Street Corp filed a Schedule 13G disclosing a passive 4.1% stake in CytomX Therapeutics as of September 30, 2026, down from the 5.0%+ threshold that would require a 13G filing. The filing is a routine passive ownership update with no activist intent.

Key Financial Metrics

Stake
4.1%
Investor
State Street Corp

Key Facts

  • State Street Corp disclosed beneficial ownership of 9,025,855 shares of CytomX Therapeutics common stock as of September 30, 2026.
  • The stake represents 4.1% of shares outstanding, below the 5% threshold that would trigger a 13G filing requirement.
  • State Street certifies the securities were acquired and held in the ordinary course of business with no intent to influence control.
  • This is a new Schedule 13G filing (not an amendment) for State Street, which previously filed an initial 13G on August 7, 2026.

Financial Impact

State Street holds 9,025,855 shares, approximately 4.1% of CTMX outstanding shares, valued at roughly $19.5M based on the $477M market cap.

ownership

Risk Factors

  • State Street's stake is passive and below 5%, indicating reduced institutional conviction compared to the prior 5.4% stake held by Bank of America.
  • No activist intent is signaled; the filing is purely administrative.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000093751-26-000642
Document: 0000093751-26-000642-index.html0000093751-26-000642
Document: 0000093751-26-000642.txt0000093751-26-000642

US Market Status

Market Closed · Opens in 6h

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026